PON1 and atherosclerosis: Cardioprotective effect against Dox-induced cardiotoxicity in rats via the reduction in GSH, LDH, and creatine kinase-MB (Hassanpour Fard et al., 2011); prevents the onset of atherosclerosis progression by increasing expression of hepatocyte paraoxonase 1 expression in a dose-dependent manner (Khateeb et al., 2010); decrease advanced atherosclerotic progression and reduce plaque necrosis in Apoe–/– mice (Manickam et al., 2022)